As regenerative medicine becomes more and more popular, research and development of new products also accelerates. While stem cells continue to be the backbone of regenerative medicine, much research has shown great promise in products made from components of the amniotic fluid. These products do not actually contain any stem cells, however greatly stimulate the healing of tissue in the same manner. They are called ‘stem cell recruitment products’ and we have seen excellent results when applied to degenerative joints. Stem cells used for treatment of joint pain come from tissue layers of the umbilical cord and inside the placenta. In contrast, amnio technology takes cell components from the amniotic fluid and combines them with certain proteins and growth factors specific to cells that make up your joints. These are the raw materials/building blocks your body can use to create new cells with and help heal degenerative tissue.
While the popularity of these exciting new medical breakthroughs grow, insurance companies have started taking notice and beginning to offer coverage for certain regenerative medicine products. Despite the slow (and mostly negative) response from orthopedic and traditional medical physicians, the results of regenerative medicine amnio technology has fortunately caught the attention of Medicare. Products such as Flower Amnio Flow ™ are now covered services (pending pre-authorization) by Medicare and offer new hope to the greatest population suffering with failing joints and facing joint replacement surgery. For more information about this new product, contact us.